NDC 50228-461 – Carbidopa and Levodopa

Carbidopa 50 mg/1; Levodopa 200 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC50228-461

Product details

Brand name
Carbidopa and Levodopa
Generic name
Carbidopa and Levodopa
Labeler
ScieGen Pharmaceuticals Inc
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA214091
Marketed since
October 5, 2021
Listing expires
December 31, 2027
Pharmacologic class
Aromatic Amino Acid

Active ingredients

Uses, dosage, side effects and warnings for Carbidopa and Levodopa →

Package NDC codes (3)

Package NDCDescriptionSince
50228-461-01100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-461-01)Oct 5, 2021
50228-461-101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-461-10)Oct 5, 2021
50228-461-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-461-30)Oct 5, 2021

Other Carbidopa and Levodopa products